Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Merck Agrees to Pay $4.85 Bln in Vioxx Settlement
Link ID 651
Title Merck Agrees to Pay $4.85 Bln in Vioxx Settlement
Url http://www.medscape.com/viewarticle/565615?src=rss
Description Merck & Co has agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes in thousands of users, the drugmaker said on Friday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Nov 12, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Contaminant in Heparin Discovered; Adverse Reactions Now Also in Germany
  The FDA is requesting all heparin manufacturers to test products for this contaminant. Increased rates of adverse reactions have now also been reported in Germany with heparin not made by Baxter or its supplier, Scientific Protein Laboratories. Heartwire
Category:   Articles > Business of Medicine


2. Cultural Competency in Healthcare: A Clinical Review and Video Vignettes From the National Medical A
  Clinician-patient vignettes demonstrate 3 areas of cultural challenges for healthcare providers: bias, language barriers, and communication problems. Medscape Internal Medicine
Category:   Articles > Business of Medicine


3. Workplace Health Program Is Cost-Effective, Improves Productivity
  DirecTV has seen an increase in employee productivity and a decrease in days lost to illness after committing to an aggressive approach to workplace health. Medscape Medical News
Category:   Articles > Business of Medicine


4. WellPoint Developing Drug Safety Monitoring System
  Health insurer WellPoint Inc said on Tuesday it is developing a system that will use its 35 million-member database to monitor and help to more quickly identify potential safety problems of approved medicines. Reuters Health Information
Category:   Articles > Business of Medicine


5. Japan Researcher Proposes Banking Induced Pluripotent Stem Cells
  Creating a bank to store induced pluripotent stem cells (iPS cells), generated from fibroblasts, could help reduce time and money for treating patients with regenerative medicine in the future, a Japanese researcher said on Wednesday. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS